Comprehensive views toward the biomolecular recognition of an anticancer drug, leflunomide with human serum albumin
Biomolecular association of an anticancer drug, leflunomide (LEF) with human serum albumin (HSA), the leading ligands carrier in human circulation was characterized using biophysical (i.e., fluorescence, absorption and voltammetric) methods and computational (i.e., molecular docking and molecular dy...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Article |
Published: |
Taylor & Francis
2024
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/47165/ https://doi.org/10.1080/07391102.2023.2239931 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
my.um.eprints.47165 |
---|---|
record_format |
eprints |
spelling |
my.um.eprints.471652024-12-30T02:15:26Z http://eprints.um.edu.my/47165/ Comprehensive views toward the biomolecular recognition of an anticancer drug, leflunomide with human serum albumin Kabir, Md. Zahirul Tayyab, Hafsa Erkmen, Cem Mohamad, Saharuddin B. Uslu, Bengi QH Natural history RS Pharmacy and materia medica Biomolecular association of an anticancer drug, leflunomide (LEF) with human serum albumin (HSA), the leading ligands carrier in human circulation was characterized using biophysical (i.e., fluorescence, absorption and voltammetric) methods and computational (i.e., molecular docking and molecular dynamics simulation) techniques. Evaluations of fluorescence, absorption and voltammetric findings endorsed the complex formation between LEF and HSA. An inverse relationship of Stern-Volmer constant-temperature and hyperchromic shift of the protein's absorption signal with addition of LEF con-firmed the LEF quenched the HSA fluorescence through static process. Moderate nature of binding strength (binding constant = 2.76-4.77 x 10(4) M-1) was detected towards the LEF-HSA complexation, while the association process was naturally driven via hydrophobic interactions, van der Waals interactions and hydrogen bonds, as evident from changes in entropy (?S= + 19.91 J mol K--1(-1)) and enthalpy (?H = -20.09 kJ mol (-1)), and molecular docking assessments. Spectral analyses of synchron-ous and three-dimensional fluorescence validated microenvironmental fluctuations near Trp and Tyr residues upon LEF binding to the protein. LEF association with HSA significantly defended tempera-ture-induced destabilization of the protein. Although LEF was found to attach to HSA at Sudlow's sites I and II, but exhibited greater preference toward its site I, as detected by the investigations of com-petitive site-marker displacement. Molecular dynamics simulation assessment revealed that the com-plex attained equilibrium throughout simulations, showing the LEF-HSA complex constancy. Taylor & Francis 2024-09 Article PeerReviewed Kabir, Md. Zahirul and Tayyab, Hafsa and Erkmen, Cem and Mohamad, Saharuddin B. and Uslu, Bengi (2024) Comprehensive views toward the biomolecular recognition of an anticancer drug, leflunomide with human serum albumin. Journal of Biomolecular Structure and Dynamics, 42 (14). pp. 7257-7271. ISSN 0739-1102, DOI https://doi.org/10.1080/07391102.2023.2239931 <https://doi.org/10.1080/07391102.2023.2239931>. https://doi.org/10.1080/07391102.2023.2239931 10.1080/07391102.2023.2239931 |
institution |
Universiti Malaya |
building |
UM Library |
collection |
Institutional Repository |
continent |
Asia |
country |
Malaysia |
content_provider |
Universiti Malaya |
content_source |
UM Research Repository |
url_provider |
http://eprints.um.edu.my/ |
topic |
QH Natural history RS Pharmacy and materia medica |
spellingShingle |
QH Natural history RS Pharmacy and materia medica Kabir, Md. Zahirul Tayyab, Hafsa Erkmen, Cem Mohamad, Saharuddin B. Uslu, Bengi Comprehensive views toward the biomolecular recognition of an anticancer drug, leflunomide with human serum albumin |
description |
Biomolecular association of an anticancer drug, leflunomide (LEF) with human serum albumin (HSA), the leading ligands carrier in human circulation was characterized using biophysical (i.e., fluorescence, absorption and voltammetric) methods and computational (i.e., molecular docking and molecular dynamics simulation) techniques. Evaluations of fluorescence, absorption and voltammetric findings endorsed the complex formation between LEF and HSA. An inverse relationship of Stern-Volmer constant-temperature and hyperchromic shift of the protein's absorption signal with addition of LEF con-firmed the LEF quenched the HSA fluorescence through static process. Moderate nature of binding strength (binding constant = 2.76-4.77 x 10(4) M-1) was detected towards the LEF-HSA complexation, while the association process was naturally driven via hydrophobic interactions, van der Waals interactions and hydrogen bonds, as evident from changes in entropy (?S= + 19.91 J mol K--1(-1)) and enthalpy (?H = -20.09 kJ mol (-1)), and molecular docking assessments. Spectral analyses of synchron-ous and three-dimensional fluorescence validated microenvironmental fluctuations near Trp and Tyr residues upon LEF binding to the protein. LEF association with HSA significantly defended tempera-ture-induced destabilization of the protein. Although LEF was found to attach to HSA at Sudlow's sites I and II, but exhibited greater preference toward its site I, as detected by the investigations of com-petitive site-marker displacement. Molecular dynamics simulation assessment revealed that the com-plex attained equilibrium throughout simulations, showing the LEF-HSA complex constancy. |
format |
Article |
author |
Kabir, Md. Zahirul Tayyab, Hafsa Erkmen, Cem Mohamad, Saharuddin B. Uslu, Bengi |
author_facet |
Kabir, Md. Zahirul Tayyab, Hafsa Erkmen, Cem Mohamad, Saharuddin B. Uslu, Bengi |
author_sort |
Kabir, Md. Zahirul |
title |
Comprehensive views toward the biomolecular recognition of an anticancer drug, leflunomide with human serum albumin |
title_short |
Comprehensive views toward the biomolecular recognition of an anticancer drug, leflunomide with human serum albumin |
title_full |
Comprehensive views toward the biomolecular recognition of an anticancer drug, leflunomide with human serum albumin |
title_fullStr |
Comprehensive views toward the biomolecular recognition of an anticancer drug, leflunomide with human serum albumin |
title_full_unstemmed |
Comprehensive views toward the biomolecular recognition of an anticancer drug, leflunomide with human serum albumin |
title_sort |
comprehensive views toward the biomolecular recognition of an anticancer drug, leflunomide with human serum albumin |
publisher |
Taylor & Francis |
publishDate |
2024 |
url |
http://eprints.um.edu.my/47165/ https://doi.org/10.1080/07391102.2023.2239931 |
_version_ |
1819909894347685888 |
score |
13.244413 |